True Wealth Design’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-108
Closed -$2.69K – 2604
2026
Q2
$2.69K Sell
108
-128
-54% -$3K ﹤0.01% 1569
2026
Q1
$3.31K Hold
236
– – ﹤0.01% 1365
2025
Q4
$2.65K Sell
236
-485
-67% -$5.55K ﹤0.01% 1349
2025
Q3
$8.34K Buy
721
+221
+44% +$2.59K ﹤0.01% 897
2025
Q2
$6.12K Buy
+500
New +$6.29K ﹤0.01% 735
2024
Q4
– Sell
-15
Closed -$361 – 1371
2024
Q3
$361 Buy
+15
New +$343 ﹤0.01% 1139

Other funds holding AVNS

True Wealth Design's AVNS Position: Q3 2026 in Review

True Wealth Design sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 108 shares — an estimated $2.69K sold.

True Wealth Design first reported a position in AVNS in Q3 2024 and held it in 6 quarters. The position peaked at $8.34K in Q3 2025. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • True Wealth Design reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • True Wealth Design sold 108 Avanos Medical shares in Q3 2026, an estimated $2.69K.
  • True Wealth Design first reported a position in Avanos Medical in Q3 2024 and held it in 6 quarters.
  • True Wealth Design's Avanos Medical position peaked at $8.34K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.